This study proposes a systematic approach to identifying B‐cell epitopes from SARS‐CoV‐2 proteins, leveraging the available nAbs repertoire against Spike and N proteins, as well as human sera from vaccinated and COVID‐19 convalescent individuals. This evidence concerns the gene CHMP5 and COVID-19.